# EDGAR Filing Document

**Accession Number:** 0001874252
**File Stem:** 0001213900-25-124689
**Filing Date:** 2025-12
**Character Count:** 2427
**Document Hash:** 5992b914da820a8b84b44ebba7e19d24
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-124689.hdr.sgml**: 20260701

**ACCESSION NUMBER**: 0001213900-25-124689

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251222

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MAINZ BIOMED N.V.
- **CENTRAL INDEX KEY:** 0001874252
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** P7
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROBERT KOCH STRASSE 50
- **CITY:** MAINZ
- **PROVINCE COUNTRY:** 2M
- **BUSINESS PHONE:** 49 6131 5542860

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROBERT KOCH STRASSE 50
- **CITY:** MAINZ
- **PROVINCE COUNTRY:** 2M

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MAINZ BIOMED N.V.
- **DATE OF NAME CHANGE:** 20211112

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Mainz Biomed B.V.
- **DATE OF NAME CHANGE:** 20210721

December 22, 2025

***<u>Via EDGAR</u>***

U.S. Securities and Exchange Commission<br> Division of Corporation Finance<br> 100 F Street, N.E.<br> Washington, DC 20549-4720

---

| | |
|:---|:---|
| **Re:** | **Mainz Biomed N.V.** |
|  | **Registration Statement on Form F-3** |
|  | **File No. 333-291979** |

---

---

| |
|:---|
| **Acceleration Request** |
| **Requested Date: December 29, 2025** |
| **Requested Time: 5:00 P.M. Eastern Time** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mainz Biomed N.V. (the "Company") hereby requests that the above-referenced Registration Statement on Form F-3 (Registration No. 333-291979) (the "Registration Statement") be declared effective at the "Requested Date" and "Requested Time" set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Ortoli Rosenstadt LLP, by calling Tim Dockery at (212) 829-8946.

MAINZ BIOMED N.V.

---

| | |
|:---|:---|
| By: | /s/ William Caragol |
| Name: | William Caragol |
| Title: | Chief Financial Officer |

---